These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Imaging and fluid biomarkers in frontotemporal dementia. Meeter LH; Kaat LD; Rohrer JD; van Swieten JC Nat Rev Neurol; 2017 Jul; 13(7):406-419. PubMed ID: 28621768 [TBL] [Abstract][Full Text] [Related]
12. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum. Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947 [TBL] [Abstract][Full Text] [Related]
13. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027 [TBL] [Abstract][Full Text] [Related]
14. Review: Clinical, genetic and neuroimaging features of frontotemporal dementia. Convery R; Mead S; Rohrer JD Neuropathol Appl Neurobiol; 2019 Feb; 45(1):6-18. PubMed ID: 30582889 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study. Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576 [TBL] [Abstract][Full Text] [Related]
17. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Snowden JS; Thompson JC; Stopford CL; Richardson AM; Gerhard A; Neary D; Mann DM Brain; 2011 Sep; 134(Pt 9):2478-92. PubMed ID: 21840888 [TBL] [Abstract][Full Text] [Related]
18. New insights into biological markers of frontotemporal lobar degeneration spectrum. Borroni B; Alberici A; Archetti S; Magnani E; Di Luca M; Padovani A Curr Med Chem; 2010; 17(10):1002-9. PubMed ID: 20156164 [TBL] [Abstract][Full Text] [Related]
19. [Frontotemporal dementia: Review of 63 cases]. Donoso S A; Figueroa V C; Gómez R R; Behrens P MI Rev Med Chil; 2009 Jul; 137(7):900-5. PubMed ID: 19802417 [TBL] [Abstract][Full Text] [Related]
20. Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies. Koren SA; Galvis-Escobar S; Abisambra JF Neurobiol Dis; 2020 Jul; 141():104939. PubMed ID: 32413399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]